Clinical staging for cutaneous T-cell lymphoma.

Area of Science:

• Oncology
• Dermatology
• Clinical Research

Background:

• Cutaneous T-cell lymphoma (CTCL), encompassing mycosis fungoides and Sézary syndrome, requires prognostic indicators.
• Previous research identified skin involvement and lymph node status as key prognostic variables in CTCL.

Purpose of the Study:

• To validate a clinical staging system for CTCL based on skin and lymph node involvement.
• To assess the system's utility in predicting survival outcomes for patients with mycosis fungoides and Sézary syndrome.

Main Methods:

• A cohort of 340 patients with CTCL was followed by the Mycosis Fungoides Cooperative Group.
• Patients were classified into four clinical stages using extent of skin involvement and number of enlarged lymph node sites.
• Survival data was analyzed to evaluate the staging system's predictive power.

Main Results:

• The clinical staging system, based on skin and lymph node assessment, demonstrated usefulness in differentiating patient survival experiences.
• Additional follow-up data confirmed the prognostic value of the established staging system.
• An alternative staging approach using survival modeling was also explored.

Conclusions:

• The proposed clinical staging system for CTCL, relying on readily available physical examination data (skin involvement and lymph nodes), is recommended for general clinical use.
• This staging system aids in identifying patients with distinct survival trajectories.
• The findings support the use of a simplified staging approach for improved patient management in CTCL.